Canadian AIDS Treatment Information Exchange

Table of Contents: CATIE News - 1999
Canadian AIDS Treatment Information Exchange
Edited by: Alan Boutilier and Sean Hosein

 

 

Table Of Contents

December
Strange vision problems associated with Serzone; Aldara for mollusca -- a promising experiment; A new option for cervical cancer; FDA gives nod to twice-daily nelfinavir; Gilead halts development of adefovir for HIV infection
November
Glutamine and antioxidant supplements for AIDS-related wasting; Four new clinical trials now enrolling in Canada; FDA rejects adefovir; Coverage of European AIDS Conference on the Web;
October
New 3TC trial now enrolling in Canada; IV Positive - an educational video about drug use and HIV; A warning about Viagra and indinavir; F-ddA trials stopped due to death; Two new trials recruiting patients in Canada; Risk factors for ritonavir intolerance (ICAAC 1999); Ketoconazole for boosting PI levels in the brain (ICAAC 1999); Stopping PCP prophylaxis (ICAAC 1999); Substituting efavirenz in patients with PI-associated lipodystrophy (ICAAC 1999); Calcium for nelfinavir-related diarrhea (ICAAC 1999)
Copyright / Funding / How to reach CATIE
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,1999. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.